Analyst Ratings for Anika Therapeutics (ANIk)
ANIk Rating Summary
ANIk Price Target Summary
- Highest: $23.00 (B.Riley)
- Lowest: $23.00 (B.Riley)
- Average: $23.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$23.00 (+15.1%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Avg. $ Target:
$23.00 (+15.1%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/18/2026 | B.Riley | Madison El-Saadi | New Coverage | Buy (N/A) |
23.00 (N/A) |
21.03 (19.98) |
-4.99% | Details |
| 8/14/2023 | Barrington Research | Michael Petusky | Upgrade | Outperform (Market Perform) |
24.00 (N/A) |
18.38 (19.98) |
8.71% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
